LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 106 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,689 | -52.4% | 42,834 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $98,090 | -5.8% | 42,834 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $104,087 | +149.6% | 42,834 | +96.2% | 0.00% | – |
| Q4 2022 | $41,705 | -56.6% | 21,835 | -45.5% | 0.00% | -100.0% |
| Q3 2022 | $96,134 | -4.7% | 40,056 | +56.4% | 0.00% | 0.0% |
| Q4 2021 | $100,880 | -18.1% | 25,604 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $123,155 | -17.9% | 25,604 | +7.4% | 0.00% | -50.0% |
| Q2 2019 | $149,972 | +13.1% | 23,843 | 0.0% | 0.00% | +100.0% |
| Q1 2019 | $132,567 | -16.3% | 23,843 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $158,318 | -37.8% | 23,843 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $254,405 | -11.0% | 23,843 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $286,000 | +40.2% | 23,843 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $204,000 | -13.6% | 23,843 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $236,000 | – | 23,843 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 71,178,364 | $280,443,000 | 7.61% |
| BVF INC/IL | 14,360,000 | $56,578,000 | 2.05% |
| Integral Health Asset Management, LLC | 200,000 | $788,000 | 0.22% |
| Eversept Partners, LP | 797,694 | $3,142,914 | 0.20% |
| NEA Management Company, LLC | 2,382,286 | $9,386,000 | 0.19% |
| PINNACLE ASSOCIATES LTD | 2,127,662 | $8,383,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $141,000 | 0.06% |
| Virtus ETF Advisers LLC | 41,584 | $164,000 | 0.06% |
| Campbell & CO Investment Adviser LLC | 11,900 | $47,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 31,562 | $124,000 | 0.02% |